|
Lee P. Shulman, MD, FACMG, FACOG
Speaker Bureaus: Barr Pharmaceuticals, Inc., Bayer, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Ortho-McNeil, Inc., Roche Laboratories, Schering-Plough Corporation, Ther-Rx Corporation, and Wyeth Pharmaceuticals
Consultant: Barr Pharmaceuticals, Inc., Bayer, Johnson & Johnson, Ortho-McNeil, Inc., and Schering-Plough Corporation
Research Grants: Barr Pharmaceuticals, Inc.
Marlene P. Freeman, MD
Research Grants: Eli Lilly and Company, Forest Laboratories (pending), and GlaxoSmithKline (originally funded by Reliant [pending])
James McGregor, MD, CM
Speaker Bureau: Ther-Rx Corporation
Consultant: Genzyme Corporation and Ther-Rx Corporation
Barry S. Skikne, MD
Speaker Bureau: Novartis Pharmaceuticals, Inc.
Research Grants: Celgene Corporation
Stock Shareholder: Elan Pharmaceuticals, Inc., Genentech, Inc., Pfizer, Inc., and Takeda Pharmaceuticals
Susan Wysocki, RNC, NP, FAANP
Speaker Bureaus: Barr Pharmaceuticals, Inc., Bayer, Ther-Rx Corporation, and Wyeth Pharmaceuticals
Consultant: Eli Lilly and Company
Advisory Boards: Barr Pharmaceuticals, Inc., Bayer, Eli Lilly and Company, Merck & Co., Inc., Ortho-McNeil, Inc., and Wyeth Pharmaceuticals
|